ArticleWiener klinische Wochenschrift2024

High-density lipoprotein (HDL) has an impact on myeloma outcome: Lower HDL associates with worse progression-free survival.

Işıl Erdoğan Özünal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.